The American Red Cross, along with national blood banks like Vitalant and OneBlood, are conducting the study. The study aims to enroll 2,000 men through 11 national blood banks in several participating cities. Last year, the FDA launched a study known as ADVANCE, or Assessing Donor Variability and New Concepts in Eligibility, to examine whether the three-month donor deferral period can be amended based on an individual risk assessment.
